Human papillomavirus (HPV) Vaccines Market is poised to value USD 8839 million by 2028 end at a CAGR of 12.4% during the forecast period 2022 to 2028.

Human papillomavirus (HPV) transmission occurs when individuals with similar skin tones interact. Your genital area, mouth, or neck may be affected by HPV, which is spread through sexual activity. The Centers for Disease Control and Prevention (CDC) report that HPV is the most frequent infection. Despite having few sexual partners, most people who engage in sexual activity will eventually contract one or more of its variants. There may be no negative health effects from some genitourinary HPV infections. Certain HPV subtypes, however, have been linked to neck, uterine, and even anus malignancies. The human papillomavirus vaccine is used to treat people who have a viral infection that was contracted through skin-to-skin contact. An additional sexually transmitted infection is the human papillomavirus (HPV). The herpes virus, often known as HSV and HIV, is different from the HPV virus. The human papillomavirus (HPV) vaccine shields the body from numerous types of infection. The rising demand for HPV vaccinations is likely to be the main driver of the global market potential for human papillomavirus vaccines during the forecast period due to the rising prevalence of HPV-related disorders. Bivalent, quadrivalent, and nonavalent vaccinations are the only kind available on the market. The approval of novel HPV vaccines and rising government and private organisation activities for early screening and vaccination are the main drivers of the market for human papillomavirus (HPV) vaccinations. In the upcoming years, the market is expected to experience healthy expansion as a result of factors including the rising prevalence of HPV-associated malignancies such anal, oropharynx, and genital parts cancers and the rising need for HPV vaccines to help prevent infections.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Human Papillomavirus (HPV) Vaccines Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Human Papillomavirus (HPV) Vaccines Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.   

Market Segmentation:

By Type
•    Bivalent
•    Polyvalent
By Disease Indication
•    HPV Associated Cancer
•    Genital Warts
By Distribution Channel
•    Hospitals and Retail Pharmacies
•    Retail Pharmacies
•    Government Suppliers 
•    Others
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

Human papillomavirus (HPV) Vaccines Market Sample Video:

The market is categorised into type, disease indication, distribution channel and region. The type segment is divided into bivalent and polyvalent. The disease indication segment is classified into HPV associated cancer and genital warts. The HPV associated cancer is predicted to account the largest human papillomavirus vaccines market share owing to the rising prevalence of cervical cancers in countries with the largest youth population. The distribution channel segment is bifurcated into hospitals and retail pharmacies, government suppliers and others. The hospital and retail pharmacy segment is anticipated to lead the market owing to advancements in healthcare infrastructure and increasing number of HPV patient population across the word. 

Regional Analysis:

The North America region is predicted to dominate the market during the forecast period owing to growing investments in research and development of advanced HPV vaccines along with a strong presence of key market players in the region. Merck, for instance, produced Gardasil in 2006 which could prevent infection from four HPV strains- 6,11, 16 and 18. Gardasil 9, as of 2017 is the only available HPV vaccine in the United States which was approves by FDA in December 2014. Such a limited availability of HPV vaccines has paved way for key players to conduct research activities for developing newer vaccines in the region.

Competitive Landscape:                            

The key players of the market associated are Merck Co., Inc., Glaxosmithkline Plc.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global human papillomavirus (HPV) vaccines market by type, by disease indication, by distribution channel and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics